Chemotherapy in Head and Neck Cancer
Author Information
Author(s): J.S. Tobias
Primary Institution: University College Hospital
Hypothesis
Has chemotherapy proved itself in head and neck cancer?
Conclusion
Chemotherapy shows some activity in head and neck cancer, but the overall benefit is small and often offset by toxicity.
Supporting Evidence
- Chemotherapy has shown response rates of 30-40% with certain drugs.
- Combination therapies can yield response rates as high as 75%.
- Local control improved from 40% to 75% with the addition of methotrexate to radiotherapy.
Takeaway
Chemotherapy can help some people with head and neck cancer, but it doesn't work for everyone and can make them feel sick.
Methodology
The editorial discusses various studies comparing chemotherapy with radiotherapy in patients with advanced head and neck cancer.
Potential Biases
The editorial notes that many patients have other health issues that could affect treatment outcomes.
Limitations
No single study was large enough to detect the benefit of chemotherapy with confidence.
Participant Demographics
The studies referenced included patients with advanced head and neck cancer, but specific demographics are not detailed.
Statistical Information
P-Value
0.0019
Statistical Significance
p=0.0019
Want to read the original?
Access the complete publication on the publisher's website